R.H. Bluestein & Co’s Tonix Pharmaceuticals TNXP Stock Holding History

R.H. Bluestein & Co’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Hold	0	–	-$36K	–	334
2016 Q4	–	Hold	0	–	–	–	304
2016 Q3	–	Hold	0	–	–	–	292
2016 Q2	–	Hold	0	–	–	–	155
2016 Q1	–	Hold	0	–	–	–	133
2015 Q4	–	Hold	0	–	–	–	56
2015 Q3	–	Hold	0	–	–	–	58
2015 Q2	–	Hold	0	–	–	–	49
2015 Q1	–	Hold	0	–	–	–	61
2014 Q4	–	Hold	0	–	–	–	66
2014 Q3	–	Hold	0	–	–	–	62
2014 Q2	–	Hold	0	–	–	–	52
2014 Q1	–	Hold	0	–	–	–	61
2013 Q4	–	Hold	0	–	–	–	71
2013 Q3	–	Hold	0	–	–	–	340

Other funds holding TNXP

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dialectic Capital Management Norwalk, Connecticut $155M AUM 59.34% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return